-
1
-
-
84944044033
-
Neuroinflammation in Parkinson's disease and its potential as therapeutic target
-
Wang, Q., Liu, Y. & Zhou, J. Neuroinflammation in Parkinson's disease and its potential as therapeutic target. Transl Neurodegener 4, doi:10.1186/s40035-015-0042-0 (2015).
-
(2015)
Transl Neurodegener
, vol.4
-
-
Wang, Q.1
Liu, Y.2
Zhou, J.3
-
2
-
-
84954039309
-
Receptor for advanced glycation end products and its inflammatory ligands are upregulated in amyotrophic lateral sclerosis
-
Juranek, J. K. et al. Receptor for Advanced Glycation End Products and its Inflammatory Ligands are Upregulated in Amyotrophic Lateral Sclerosis. Front Cell Neurosci 9, doi:10.3389/fncel.2015.00485 (2015).
-
(2015)
Front Cell Neurosci
, vol.9
-
-
Juranek, J.K.1
-
3
-
-
84859723641
-
A multimodal RAGE-specific inhibitor reduces amyloid beta-mediated brain disorder in a mouse model of Alzheimer disease
-
Deane, R. et al. A multimodal RAGE-specific inhibitor reduces amyloid beta-mediated brain disorder in a mouse model of Alzheimer disease. J Clin Invest 122, 1377-1392, doi:10.1172/jci58642 (2012).
-
(2012)
J Clin Invest
, vol.122
, pp. 1377-1392
-
-
Deane, R.1
-
4
-
-
84864379214
-
Receptor for advanced glycation endproducts (RAGE) deficiency protects against MPTP toxicity
-
Teismann, P. et al. Receptor for advanced glycation endproducts (RAGE) deficiency protects against MPTP toxicity. Neurobiology of aging 33, 2478-2490, doi:10.1016/j.neurobiolaging.2011.12.006 (2012).
-
(2012)
Neurobiology of Aging
, vol.33
, pp. 2478-2490
-
-
Teismann, P.1
-
5
-
-
84978993731
-
Protective efficacy of P7C3-S243 in the 6-hydroxydopamine model of Parkinson's disease
-
De Jesus-Cortes, H. et al. Protective efficacy of P7C3-S243 in the 6-hydroxydopamine model of Parkinson's disease. NPJ Parkinsons Dis 1, doi:10.1038/npjparkd.2015.10 (2015).
-
(2015)
NPJ Parkinsons Dis
, vol.1
-
-
De Jesus-Cortes, H.1
-
6
-
-
84857869793
-
Development of a unilaterally-lesioned 6-OHDA mouse model of Parkinson's disease
-
Thiele, S. L., Warre, R. & Nash, J. E. Development of a unilaterally-lesioned 6-OHDA mouse model of Parkinson's disease. J Vis Exp. doi:10.3791/3234 (2012).
-
(2012)
J Vis Exp.
-
-
Thiele, S.L.1
Warre, R.2
Nash, J.E.3
-
7
-
-
84953287235
-
Effects of RAGE-specific inhibitor FPS-ZM1 on amyloid-beta metabolism and AGEs-induced inflammation and oxidative stress in rat hippocampus
-
Hong, Y. et al. Effects of RAGE-Specific Inhibitor FPS-ZM1 on Amyloid-beta Metabolism and AGEs-Induced Inflammation and Oxidative Stress in Rat Hippocampus. Neurochem Res 41, 1192-1199, doi:10.1007/s11064-015-1814-8 (2016).
-
(2016)
Neurochem Res
, vol.41
, pp. 1192-1199
-
-
Hong, Y.1
-
8
-
-
84933528303
-
Receptor for advanced glycation end-product antagonist reduces blood-brain barrier damage after intracerebral hemorrhage
-
Yang, F. et al. Receptor for advanced glycation end-product antagonist reduces blood-brain barrier damage after intracerebral hemorrhage. Stroke 46, 1328-1336, doi:10.1161/strokeaha.114.008336 (2015).
-
(2015)
Stroke
, vol.46
, pp. 1328-1336
-
-
Yang, F.1
-
9
-
-
42549135904
-
Inflammation and the redox-sensitive AGE-RAGE pathway as a therapeutic target in Alzheimer's disease
-
Maczurek, A., Shanmugam, K. & Munch, G. Inflammation and the redox-sensitive AGE-RAGE pathway as a therapeutic target in Alzheimer's disease. Annals of the New York Academy of Sciences 1126, 147-151, doi:10.1196/annals.1433.026 (2008).
-
(2008)
Annals of the New York Academy of Sciences
, vol.1126
, pp. 147-151
-
-
Maczurek, A.1
Shanmugam, K.2
Munch, G.3
-
10
-
-
84881118554
-
Cellular signalling of the receptor for advanced glycation end products (RAGE)
-
Xie, J., Mendez, J. D., Mendez-Valenzuela, V. & Aguilar-Hernandez, M. M. Cellular signalling of the receptor for advanced glycation end products (RAGE). Cellular signalling 25, 2185-2197, doi:10.1016/j.cellsig.2013.06.013 (2013).
-
(2013)
Cellular Signalling
, vol.25
, pp. 2185-2197
-
-
Xie, J.1
Mendez, J.D.2
Mendez-Valenzuela, V.3
Aguilar-Hernandez, M.M.4
-
11
-
-
84920609361
-
Receptor for AGEs (RAGE) as mediator of NF-kB pathway activation in neuroinflammation and oxidative stress
-
Tobon-Velasco, J. C., Cuevas, E. & Torres-Ramos, M. A. Receptor for AGEs (RAGE) as mediator of NF-kB pathway activation in neuroinflammation and oxidative stress. CNS & neurological disorders drug targets 13, 1615-1626 (2014).
-
(2014)
CNS & Neurological Disorders Drug Targets
, vol.13
, pp. 1615-1626
-
-
Tobon-Velasco, J.C.1
Cuevas, E.2
Torres-Ramos, M.A.3
-
12
-
-
9744239461
-
Tyrosine hydroxylase phosphorylation: Regulation and consequences
-
Dunkley, P. R., Bobrovskaya, L., Graham, M. E., von Nagy-Felsobuki, E. I. & Dickson, P. W. Tyrosine hydroxylase phosphorylation: regulation and consequences. Journal of neurochemistry 91, 1025-1043, doi:10.1111/j.1471-4159.2004.02797.x (2004)
-
(2004)
Journal of Neurochemistry
, vol.91
, pp. 1025-1043
-
-
Dunkley, P.R.1
Bobrovskaya, L.2
Graham, M.E.3
Von Nagy-Felsobuki, E.I.4
Dickson, P.W.5
-
13
-
-
77953800114
-
Characterisation of behavioural and neurodegenerative changes induced by intranigral 6-hydroxydopamine lesions in a mouse model of Parkinson's disease
-
Grealish, S., Mattsson, B., Draxler, P. & Bjorklund, A. Characterisation of behavioural and neurodegenerative changes induced by intranigral 6-hydroxydopamine lesions in a mouse model of Parkinson's disease. Eur J Neurosci 31, 2266-2278, doi:10.1111/j.1460-9568.2010.07265.x (2010).
-
(2010)
Eur J Neurosci
, vol.31
, pp. 2266-2278
-
-
Grealish, S.1
Mattsson, B.2
Draxler, P.3
Bjorklund, A.4
-
14
-
-
34548458484
-
The 6-hydroxydopamine model of Parkinson's disease
-
Simola, N., Morelli, M. & Carta, A. R. The 6-hydroxydopamine model of Parkinson's disease. Neurotox Res 11, 151-167 (2007).
-
(2007)
Neurotox Res
, vol.11
, pp. 151-167
-
-
Simola, N.1
Morelli, M.2
Carta, A.R.3
-
15
-
-
0141741347
-
Parkinson's disease: Mechanisms and models
-
Dauer, W. & Przedborski, S. Parkinson's disease: mechanisms and models. Neuron 39, 889-909 (2003).
-
(2003)
Neuron
, vol.39
, pp. 889-909
-
-
Dauer, W.1
Przedborski, S.2
-
16
-
-
84903782549
-
Genetic deficiency of neuronal RAGE protects against AGE-induced synaptic injury
-
Zhang, H. et al. Genetic deficiency of neuronal RAGE protects against AGE-induced synaptic injury. Cell death & disease 5, e1288, doi:10.1038/cddis.2014.248 (2014).
-
(2014)
Cell Death & Disease
, vol.5
, pp. e1288
-
-
Zhang, H.1
-
17
-
-
84953931462
-
RAGE axis in neuroinflammation, neurodegeneration and its emerging role in the pathogenesis of amyotrophic lateral sclerosis
-
Ray, R., Juranek, J. K. & Rai, V. RAGE axis in neuroinflammation, neurodegeneration and its emerging role in the pathogenesis of amyotrophic lateral sclerosis. Neuroscience and biobehavioral reviews 62, 48-55, doi:10.1016/j.neubiorev.2015.12.006 (2016).
-
(2016)
Neuroscience and Biobehavioral Reviews
, vol.62
, pp. 48-55
-
-
Ray, R.1
Juranek, J.K.2
Rai, V.3
-
18
-
-
0034798997
-
Rapid morphological changes in astrocytes are accompanied by redistribution but not by quantitative changes of cytoskeletal proteins
-
Safavi-Abbasi, S., Wolff, J. R. & Missler, M. Rapid morphological changes in astrocytes are accompanied by redistribution but not by quantitative changes of cytoskeletal proteins. Glia 36, 102-115 (2001).
-
(2001)
Glia
, vol.36
, pp. 102-115
-
-
Safavi-Abbasi, S.1
Wolff, J.R.2
Missler, M.3
-
19
-
-
84946401009
-
Altered morphological dynamics of activated microglia after induction of status epilepticus
-
Avignone, E., Lepleux, M., Angibaud, J. & Nägerl, U. V. Altered morphological dynamics of activated microglia after induction of status epilepticus. J Neuroinflammation 12, doi:10.1186/s12974-015-0421-6 (2015).
-
(2015)
J Neuroinflammation
, vol.12
-
-
Avignone, E.1
Lepleux, M.2
Angibaud, J.3
Nägerl, U.V.4
-
20
-
-
84878897062
-
Altered nucleolar morphology in substantia nigra dopamine neurons following 6-hydroxydopamine lesion in rats
-
Healy-Stoffel, M., Ahmad, S. O. & Stanford, J. A. & Levant, B. Altered nucleolar morphology in substantia nigra dopamine neurons following 6-hydroxydopamine lesion in rats. Neurosci Lett 546, 26-30, doi:10.1016/j.neulet.2013.04.033 (2013).
-
(2013)
Neurosci Lett
, vol.546
, pp. 26-30
-
-
Healy-Stoffel, M.1
Ahmad, S.O.2
Stanford, J.A.3
Levant, B.4
-
21
-
-
26444478269
-
Advanced glycation end products and RAGE: A common thread in aging, diabetes, neurodegeneration, and inflammation
-
Ramasamy, R. et al. Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. Glycobiology 15, 16r-28r, doi:10.1093/glycob/cwi053 (2005).
-
(2005)
Glycobiology
, vol.15
, pp. 16-28
-
-
Ramasamy, R.1
-
22
-
-
0030910830
-
Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products
-
Li, J. & Schmidt, A. M. Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products. The Journal of biological chemistry 272, 16498-16506 (1997).
-
(1997)
The Journal of Biological Chemistry
, vol.272
, pp. 16498-16506
-
-
Li, J.1
Schmidt, A.M.2
-
23
-
-
0142039004
-
The receptor for advanced glycation end-products (RAGE) directly binds to ERK by a D-domain-like docking site
-
Ishihara, K., Tsutsumi, K., Kawane, S., Nakajima, M. & Kasaoka, T. The receptor for advanced glycation end-products (RAGE) directly binds to ERK by a D-domain-like docking site. FEBS letters 550, 107-113 (2003).
-
(2003)
FEBS Letters
, vol.550
, pp. 107-113
-
-
Ishihara, K.1
Tsutsumi, K.2
Kawane, S.3
Nakajima, M.4
Kasaoka, T.5
-
24
-
-
84870168829
-
S100B is increased in Parkinson's disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-alpha pathway
-
Sathe, K. et al. S100B is increased in Parkinson's disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-alpha pathway. Brain: a journal of neurology 135, 3336-3347, doi:10.1093/brain/aws250 (2012).
-
(2012)
Brain: A Journal of Neurology
, vol.135
, pp. 3336-3347
-
-
Sathe, K.1
-
25
-
-
84962520475
-
In-vivo evidence that high mobility group box 1 exerts deleterious effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model and Parkinson's disease which can be attenuated by glycyrrhizin
-
Santoro, M. et al. In-vivo evidence that high mobility group box 1 exerts deleterious effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model and Parkinson's disease which can be attenuated by glycyrrhizin. Neurobiol Dis 91, 59-68, doi:10.1016/j. nbd.2016.02.018 (2016).
-
(2016)
Neurobiol Dis
, vol.91
, pp. 59-68
-
-
Santoro, M.1
-
26
-
-
77955057715
-
Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson's disease are predominantly associated with serotonin and dopamine
-
Santiago, R. M. et al. Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson's disease are predominantly associated with serotonin and dopamine. Progress in neuro-psychopharmacology & biological psychiatry 34, 1104-1114, doi:10.1016/j.pnpbp.2010.06.004 (2010).
-
(2010)
Progress in Neuro-psychopharmacology & Biological Psychiatry
, vol.34
, pp. 1104-1114
-
-
Santiago, R.M.1
-
27
-
-
84945275413
-
-
National Institutes of Health Guide for Careand Use of Laboratory Animals. Accessed 15 Jan 2017
-
National Institutes of Health Guide for Careand Use of Laboratory Animals. Eighth Edition. Avaiable in https://grants.nih.gov/grants/olaw/Guide-for-the-Care-and-Use-of-Laboratory-Animals.pdf Accessed 15 Jan 2017 (1985).
-
(1985)
Eighth Edition
-
-
-
28
-
-
84862571593
-
Motor and non-motor features of Parkinson's disease - A review of clinical and experimental studies
-
Lima, M. M. et al. Motor and non-motor features of Parkinson's disease - a review of clinical and experimental studies. CNS & neurological disorders drug targets 11, 439-449 (2012).
-
(2012)
CNS & Neurological Disorders Drug Targets
, vol.11
, pp. 439-449
-
-
Lima, M.M.1
-
30
-
-
84919413546
-
Increased tau phosphorylation and receptor for advanced glycation endproducts (RAGE) in the brain of mice infected with leishmania amazonensis
-
Gasparotto, J. et al. Increased tau phosphorylation and receptor for advanced glycation endproducts (RAGE) in the brain of mice infected with Leishmania amazonensis. Brain Behav Immun 43, 37-45, doi:10.1016/j.bbi.2014.06.204 (2015).
-
(2015)
Brain Behav Immun
, vol.43
, pp. 37-45
-
-
Gasparotto, J.1
-
31
-
-
84879063079
-
Probucol increases striatal glutathione peroxidase activity and protects against 3-nitropropionic acid-induced pro-oxidative damage in rats
-
Colle, D. et al. Probucol Increases Striatal Glutathione Peroxidase Activity and Protects against 3-Nitropropionic Acid-Induced Pro-Oxidative Damage in Rats. PLoS One 8, doi:10.1371/journal.pone.0067658 (2013).
-
(2013)
PLoS One
, vol.8
-
-
Colle, D.1
-
32
-
-
84923319244
-
A partial lesion model of Parkinson's disease in mice-characterization of a 6-OHDA-induced medial forebrain bundle lesion
-
Boix, J., Padel, T. & Paul, G. A partial lesion model of Parkinson's disease in mice-characterization of a 6-OHDA-induced medial forebrain bundle lesion. Behav Brain Res 284, 196-206, doi:10.1016/j.bbr.2015.01.053 (2015).
-
(2015)
Behav Brain Res
, vol.284
, pp. 196-206
-
-
Boix, J.1
Padel, T.2
Paul, G.3
-
33
-
-
0033950675
-
CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury
-
Schallert, T., Fleming, S. M., Leasure, J. L., Tillerson, J. L. & Bland, S. T. CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology 39, 777-787 (2000).
-
(2000)
Neuropharmacology
, vol.39
, pp. 777-787
-
-
Schallert, T.1
Fleming, S.M.2
Leasure, J.L.3
Tillerson, J.L.4
Bland, S.T.5
-
34
-
-
0017184389
-
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
-
Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72, 248-254 (1976).
-
(1976)
Anal Biochem
, vol.72
, pp. 248-254
-
-
Bradford, M.M.1
|